Advanced Research of Stem Cells for Regenerative Medicine
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 1739
Special Issue Editors
Interests: stem cells; regenerative medicine; oxidative stress and free radical biology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In the field of regenerative medicine, pluripotent/multipotent stem cells, able to differentiate across germ layers, have become popular candidates to cure a plethora of diseases that are currently treated based on either palliative or symptomatic relief or by preventing their onset and progression. Over a million patients worldwide have benefited from bone marrow transplantations performed for the treatment of leukemias, anemias or immunodeficiency, and skin stem cells are used to heal severe burns, while limbal stem cells can regenerate the damaged cornea. Moreover, adult stem cells have the potential to treat a variety of degenerative diseases, as well as aging. Several clinical trials of stem cell-based therapies are underway; however, there are still several challenges to overcome before stem cells may be used in a wide range of therapeutic contexts. Therefore, understanding the factors that regulate stem cell activity and differentiation is still necessary with the hope of translating these findings into the clinic.
This Special Issue "Advanced Research of Stem Cells for Regenerative Medicine" welcomes original research and review articles on topics such as the following:
- Molecular pathways implicated in stem cell aging and the development of novel strategies to bypass those pitfalls on their clinical uses;
- The current progress in tissue engineering and transplantation of each type of stem cells in regenerative medicine;
- The scaffold application and implications of nanomaterials in tissue and cell regeneration;
- Stem cell secretome and its therapeutic potential in various diseases.
Dr. Tullia Maraldi
Dr. Martina Gatti
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- stem cells
- regenerative therapy
- degenerative diseases
- aging
- tissue engineering
